FDA Warning Letter — LEVO AG

Case 717287 — FEI 1000268398

The FDA took a Warning Letter action against LEVO AG on July 16, 2025 (Wohlen Ag, Switzerland). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.

Action Details

Facility
LEVO AG
Date
July 16, 2025
Fiscal Year
2025
Product Type
Biologics
Center
CBER
Location
Wohlen Ag (Switzerland)